Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
Drug screening—i.e., testing the effects of a number of drugs in multiple cell lines—is used for drug discovery and development, and can also be performed to evaluate the heterogeneity of a disease entity. Notably, intertumoral heterogeneity is a large hurdle to overcome for esta...
Main Authors: | Jumpei Kondo, Masahiro Inoue |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/5/470 |
Similar Items
-
The role of organoids in cancer research
by: Zhen Fang, et al.
Published: (2023-08-01) -
Liver organoids and their application in liver cancer research
by: Xinyu Song, et al.
Published: (2024-03-01) -
Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
by: Zarema Gilazieva, et al.
Published: (2020-09-01) -
Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review
by: Benjamin Medle, et al.
Published: (2022-04-01) -
Cancer organoid applications to investigate chemotherapy resistance
by: Kenji Harada, et al.
Published: (2022-12-01)